Portfolio company Pluto Bio raised $3.6M to expand its AI-powered multi-omics analysis platform for pharma.
Pluto Bio is a Denver-based company specializing in AI-driven multi-omics analysis for the pharmaceutical industry
Pluto Bio is a Denver-based company specializing in AI-driven multi-omics analysis for the pharmaceutical industry. It provides data management and analysis tools for drug discovery, allowing scientists to explore large datasets and run bioinformatics pipelines without coding.